Latest News & Features
Americas
Law firm BakerHostetler has hired Allen Sokal as counsel in the firm’s intellectual property group in Washington, DC. 15 October 2015
Biotechnology
The Dutch lobby to amend Directive 98/44/EC on the legal protection of biotechnological inventions will severely damage the ability of the biotech sector to innovate—and for no tangible reason, says Annemiek Verkamman of HollandBIO. 15 October 2015
Asia
The High Court of Australia’s decision in Myriad has led some observers to hit the panic button and demand immediate legislative change, but only isolated naturally-occurring genes are affected and the ruling should be read in that light, says Grant Shoebridge of Shelston IP. 15 October 2015
Americas
Biotechnology company Enzo Biochem has settled a patent lawsuit after its rival Affymetrix agreed to pay $10 million to resolve the case. 14 October 2015
Americas
The double assessment of trademark applications for pharmaceutical products can cause problems for intellectual property owners, lawyers have claimed. 13 October 2015
Americas
Drug maker Mylan has been sued by pharmaceutical company Flamel Ireland for allegedly infringing a patent covering Coreg CR. 12 October 2015
Americas
Hedge fund manger Kyle Bass has secured his first inter partes review trial after the Patent Trial and Appeal Board instituted a challenge against a patent owned by biopharmaceutical company Shire. 9 October 2015
Americas
A US resident has been charged with trafficking counterfeit erectile dysfunction pills, the government has revealed. 8 October 2015
Big Pharma
The CJEU’s decision on how an SPC term is to be determined is likely to be welcomed by applicants and owners, but the court has left them to work out how to apply the ruling, say Natalia Wegner-Cribbs and Daniel Wise of Carpmaels & Ransford. 8 October 2015
Asia-Pacific
Australia’s highest court has said that naturally occurring nucleic acid molecules are not patentable, overturning a lower court ruling. 7 October 2015